Neurotoxicity and neurocognitive impairments with alcohol and drug-use disorders: potential roles in addiction and recovery.
This article represents the proceedings of a symposium at the 2000 RSA Meeting in Denver, Colorado. The organisers/chairs were Stephen C. Bowden and Fulton T. Crews. The presentations were (1) Age, genetic and other factors that increase risk of alcoholism also increase alcohol-induced neurotoxicity, by Fulton T. Crews; (2) A neurocognitive moderation model of addictions treatment response, by Marsha E. Bates; (3) The relationship of neurocognitive impairment and longitudinal treatment outcome among substance-abusing patients, by William Fals-Stewart; and (4) Treatment of cognition in detoxifying alcohol-dependent participants, by Margaret L. Ambrose.
School of Behavioural Science, Department of Psychology, University of Melbourne, Parkville, Victoria, Australia. s.bowden@psych.unimelb.edu.au
S C
SC
Bowden
F T
FT
Crews
M E
ME
Bates
W
W
Fals-Stewart
M L
ML
Ambrose
D000437:Alcoholism / Q000150:complications* / Q000503:physiopathology / Q000628:therapy; D000818:Animals; D001921:Brain / Q000503:physiopathology; D003072:Cognition Disorders / Q000139:chemically induced* / Q000628:therapy; D006801:Humans; D009422:Nervous System Diseases / Q000139:chemically induced* / Q000628:therapy; D019966:Substance-Related Disorders / Q000150:complications* / Q000628:therapy; D013831:Thiamine / Q000627:therapeutic use
D013831:Thiamine